MRK•benzinga•
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
Summary
Merck's Welireg wins FDA approval for rare PPGL tumors; Q1 2025 sales reach $137M, marking a 62% year-over-year increase.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 14, 2025 by benzinga